(RTTNews) - Heron Therapeutics Inc. (HRTX) announced Loss for its third quarter that increased from the same period last year and missed the Street estimates.
The company's bottom line came in at -$17.50 million, or -$0.10 per share. This compares with -$4.85 million, or -$0.03 per share, last year.
Analysts on average had expected the company to earn -$0.01 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period rose 16.5% to $38.21 million from $32.81 million last year.
Heron Therapeutics Inc. earnings at a glance (GAAP) :
-Earnings: -$17.50 Mln. vs. -$4.85 Mln. last year. -EPS: -$0.10 vs. -$0.03 last year. -Revenue: $38.21 Mln vs. $32.81 Mln last year.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
